Filing Details
- Accession Number:
- 0001493152-24-015877
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-25 11:36:44
- Reporting Period:
- 2024-04-22
- Accepted Time:
- 2024-04-25 11:36:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260641 | C James Czirr | 4908 S. Ashton Ct. Spokane, WA 99223 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-04-22 | 21,323 | $3.06 | 5,925,884 | No | 4 | S | Indirect | By 10X Fund, LP |
| Common Stock | Disposition | 2024-04-23 | 3,677 | $3.06 | 5,922,207 | No | 4 | S | Indirect | By 10X Fund, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By 10X Fund, LP |
| No | 4 | S | Indirect | By 10X Fund, LP |
Footnotes
- The securities were sold by 10X Fund, LP. James C. Czirr is the manager of 10X Capital Management, LLC, which is the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such Mr. Czirr may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
